In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.
Vera-Cabrera
Lucio
L
Servicio de Dermatologia, Hospital Universitario, Madero y Gonzalitos, Colonia Mitras Centro, Monterrey, NL, México. luvera_99@yahoo.com
Campos-Rivera
Mayra Paola
MP
Escalante-Fuentes
Wendy G
WG
Pucci
Michael J
MJ
Ocampo-Candiani
Jorge
J
Welsh
Oliverio
O
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology; D019818:Clavulanic Acid / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D004464:Econazole / Q000494:pharmacology*; D006801:Humans; D015378:Imipenem / Q000494:pharmacology*; D066298:In Vitro Techniques; D000077731:Meropenem; D008271:Mycetoma / Q000188:drug therapy / Q000382:microbiology; D009615:Nocardia / Q000187:drug effects*; D009617:Nocardia Infections / Q000188:drug therapy / Q000382:microbiology; D015363:Quinolones / Q000737:chemistry / Q000494:pharmacology*; D013844:Thiazoles / Q000737:chemistry / Q000494:pharmacology*; D013845:Thienamycins / Q000494:pharmacology*
C550937:ACH 702; D000900:Anti-Bacterial Agents; D015363:Quinolones; D013844:Thiazoles; D013845:Thienamycins; D019818:Clavulanic Acid; D004464:Econazole; D015378:Imipenem; D000077731:Meropenem